Purzner J, Brown AS, Purzner T, et al. Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma. eLife. Published online March 18, 2025. doi:https://doi.org/10.7554/elife.105339.1

Srikanthan D, Kaufmann M, Jamzad A, et al. Attention based multi-instance learning for improved glioblastoma detection using mass spectrometry. Linte CA, Siewerdsen JH, eds. Medical Imaging 2023: Image-Guided Procedures, Robotic Interventions, and Modeling. Published online April 3, 2023:34. doi:https://doi.org/10.1117/12.2654436

Yan M, Zalay O, Kennedy T, et al. Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis. Frontiers in Oncology. 2022;12. doi:https://doi.org/10.3389/fonc.2022.869572

Ye VC, Landry AP, Purzner T, et al. Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case. Journal of neurosurgery Case lessons. 2021;1(12). doi:https://doi.org/10.3171/case2078

Zhong B, Campagne O, Salloum R, Purzner T, Stewart CF. LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors. Journal of Chromatography B. 2020;1152:122254-122254. doi:https://doi.org/10.1016/j.jchromb.2020.122254

Nitta RT, Bolin S, Luo E, et al. Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene. 2019;38(42):6867-6879. doi:https://doi.org/10.1038/s41388-019-0927-y

Purzner T, Purzner J, Buckstaff T, et al. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 2018;11(547). doi:https://doi.org/10.1126/scisignal.aau5147